(Bold for FDA approved)
How Ramitax works• Binds selectively to melatonin 1 and melatonin 2 receptors as a full agonist
• Generally takes effect in less than an hour
Notable Side Effects• Sedation
• Dizziness
• Fatigue
• Headache
Life Threatening Side Effects• Respiratory depression, especially when taken with other CNS depressants in overdose
• Rare angioedema

unusual

common
• Wait
• To avoid problems with memory, only take ramelteon if planning to have a full night’s sleep
• Lower the dose
• Switch to a non-benzodiazepine sedative hypnotic
• 8 mg at bedtime
Dosage Forms• Tablet 8 mg
• No reports of dependence, tolerance, or abuse liability
• Not restricted to short-term use but few long-term studies
• No
Renal Impairment• Dose adjustment not generally necessary
Hepatic Impairment• Use with caution in patients with moderate hepatic impairment
• Not recommended for use in patients with severe impairment
Cardiac Impairment• Dosage adjustment may not be necessary
Elderly• No adjustment necessary
• Greater absorption and higher plasma drug concentrations but no increase in side effects
Children and Adolescents• Safety and efficacy have not been established
Pregnancy• Effective June 30, 2015, the FDA requires changes to the content and format of pregnancy and lactation information in prescription drug labels, including the elimination of the pregnancy letter categories; the Pregnancy and Lactation Labeling Rule (PLLR or final rule) applies only to prescription drugs and will be phased in gradually for drugs approved on or after June 30, 2001
• Controlled studies have not been conducted in pregnant women
Breast Feeding• Unknown if ramelteon is secreted in human breast milk, but all psychotropics are assumed to be secreted in breast milk
• Recommended either to discontinue drug or bottle feed
Based on data Published online by Cambridge University Press
Compiled by Dr. Jash Ajmera